Pathophysiology of NASH in endocrine diseases
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the industrialized world. NAFLD encompasses a whole spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. The latter can lead to hepatocellular carcinoma. Furthermore,...
Main Authors: | Karim Gariani, François R Jornayvaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2021-03-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/10/2/EC-20-0490.xml |
Similar Items
-
NASH-related increases in plasma bile acid levels depend on insulin resistance
by: Guillaume Grzych, et al.
Published: (2021-04-01) -
Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH
by: Laurianne Bonnet, et al.
Published: (2022-08-01) -
Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity
by: Raffaelle K. Barros, et al.
Published: (2016-05-01) -
Surveillance for Hepatocellular Carcinoma in Patients with NASH
by: Philippe Kolly, et al.
Published: (2016-06-01) -
Western Diet-Fed ApoE Knockout Male Mice as an Experimental Model of Non-Alcoholic Steatohepatitis
by: Felipe N. Camargo, et al.
Published: (2022-10-01)